Venous Malformation and Localized Intravascular Coagulopathy in Children

Judy W S Hung1, Michael W Y Leung1, Clarence S W Liu1

  • 1Division of Pediatric Surgery, Department of Surgery, Queen Elizabeth and United Christian Hospital, Hong Kong, Hong Kong.

Insights

Localized intravascular coagulopathy (LIC) affects one-third of pediatric venous malformations (VM). This condition is more prevalent in large, multifocal VMs and those with palpable phleboliths or Klippel-Trenaunay syndrome (KTS).

Area of Science:

  • Vascular Medicine
  • Pediatric Hematology
  • Diagnostic Imaging

Background:

  • Localized intravascular coagulopathy (LIC) is documented in adults with venous malformations (VM).
  • LIC occurrence in pediatric patients with VM is infrequently reported.
  • Understanding LIC prevalence and risk factors in children with VM is crucial.

Purpose of the Study:

  • To ascertain the prevalence of LIC in pediatric patients diagnosed with VM.
  • To identify potential risk factors associated with LIC in this population.
  • To analyze the relationship between VM characteristics and LIC indicators.

Main Methods:

  • Retrospective review of pediatric patients (<18 years) with VM from 2010-2014.
  • Diagnosis confirmation via Doppler ultrasound and/or MRI.
  • Assessment of demographics, VM characteristics (volume, site, extension, pain, phleboliths), and plasma D-dimer levels (>500 ng/mL considered abnormal).

Main Results:

  • Twenty-four children (8 boys, median age 9 months) were included.
  • Head-and-neck VM (70.8%) and large VM (>10 mL, 29.2%) were common.
  • Elevated D-dimer (LIC indicator) found in 33.3% of patients.
  • LIC was significantly associated with multifocal VM (p=0.028) and showed a trend with palpable phleboliths (p=0.101).
  • One patient with Klippel-Trenaunay syndrome (KTS) had markedly elevated D-dimer (5,000 ng/mL).

Conclusions:

  • One-third of pediatric VM patients exhibit LIC, indicated by elevated D-dimer levels.
  • LIC is more frequently observed in larger, multifocal VMs.
  • Risk factors for LIC in pediatric VM include palpable phleboliths and KTS.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
430
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
663
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
366
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K